Gyrus Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-386,073
Closed -$12.7M 65
2015
Q1
$12.7M Sell
386,073
-12,111
-3% -$385K 2.11% 7
2014
Q4
$11.8M Buy
398,184
+13,422
+3% +$385K 1.94% 9
2014
Q3
$10.8M Buy
384,762
+2,851
+0.7% +$80K 1.89% 9
2014
Q2
$10.8M Sell
381,911
-3,135
-0.8% -$89.4K 1.93% 7
2014
Q1
$13M Sell
385,046
-3,637
-0.9% -$108K 2.25% 4
2013
Q4
$12M Buy
388,683
+13,175
+4% +$383K 2.51% 4
2013
Q3
$10.5M Buy
375,508
+72,596
+24% +$1.98M 2.31% 4
2013
Q2
$8.49M Buy
+302,912
New +$8.37M 1.92% 14

Other funds holding PFE

Gyrus Investment Management's PFE Position: Q2 2015 in Review

Gyrus Investment Management sold out of Pfizer (PFE) in Q2 2015, closing a stake of 386,073 shares — an estimated $12.7M sold.

Gyrus Investment Management first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $13M in Q1 2014. 1,886 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Gyrus Investment Management reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Gyrus Investment Management sold 386,073 Pfizer shares in Q2 2015, an estimated $12.7M.
  • Gyrus Investment Management first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
  • Gyrus Investment Management's Pfizer position peaked at $13M in Q1 2014.
  • 1,886 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Gyrus Investment Management's 13F filing for Q2 2015.